(Q38172476)

30 August 2017

title

Cancer nanomedicine: from drug delivery to imaging (English)

1 reference

30 August 2017

1 reference

0 references

Edward Kai-Hua Chow

1

0 references

author name string

Dean Ho

series ordinal

2

1 reference

30 August 2017

language of work or name

English

0 references

publication date

1 December 2013

1 reference

Science Translational Medicine

30 August 2017

published in

1 reference

30 August 2017

volume

5

1 reference

30 August 2017

issue

216

1 reference

30 August 2017

page(s)

216rv4

1 reference

Soluble polymer carriers for the treatment of cancer: the importance of molecular architecture

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Nanotech approaches to drug delivery and imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Structure and design of polymeric surfactant-based drug delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Dendritic polymer macromolecular carriers for drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Advances in biomaterials, drug delivery, and bionanotechnology

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Cross-linked block copolymer micelles: functional nanostructures of great potential and versatility

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

The convergence of synthetic organic and polymer chemistries

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Mucus-penetrating nanoparticles for vaginal drug delivery protect against herpes simplex virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

A dense poly(ethylene glycol) coating improves penetration of large polymeric nanoparticles within brain tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Bioresorbable nanofiber-based systems for wound healing and drug delivery: optimization of fabrication parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Peptide-amphiphile nanofibers: a versatile scaffold for the preparation of self-assembling materials

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Strategy for increasing drug solubility and efficacy through covalent attachment to polyvalent DNA-nanoparticle conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Biology of TiO2-oligonucleotide nanocomposites

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Antimicrobial effects of silver nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Enhancement of in vivo anticancer effects of cisplatin by incorporation inside single-wall carbon nanohorns.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Carbon nanohorns as anticancer drug carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Applications of carbon nanotubes in drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Drug delivery with carbon nanotubes for in vivo cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Preparation of carbon nanotube bioconjugates for biomedical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Nanodiamond therapeutic delivery agents mediate enhanced chemoresistant tumor treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Active nanodiamond hydrogels for chemotherapeutic delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Protein-mediated assembly of nanodiamond hydrogels into a biocompatible and biofunctional multilayer nanofilm

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

The properties and applications of nanodiamonds

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Covalent linkage of nanodiamond-paclitaxel for drug delivery and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Codelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Use of size and a copolymer design feature to improve the biodistribution and the enhanced permeability and retention effect of doxorubicin-loaded mesoporous silica nanoparticles in a murine xenograft tumor model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Magnetic fluorescent delivery vehicle using uniform mesoporous silica spheres embedded with monodisperse magnetic and semiconductor nanocrystals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Gd(III)-nanodiamond conjugates for MRI contrast enhancement

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Nanoparticles that communicate in vivo to amplify tumour targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Layer-by-layer nanoparticles for systemic codelivery of an anticancer drug and siRNA for potential triple-negative breast cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Transport of molecules across tumor vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Diamond-lipid hybrids enhance chemotherapeutic tolerance and mediate tumor regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Near-infrared resonant nanoshells for combined optical imaging and photothermal cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

The role of the liposomal anthracyclines and other systemic therapies in the management of advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

A phase 2 study of SP1049C, doxorubicin in P-glycoprotein-targeting pluronics, in patients with advanced adenocarcinoma of the esophagus and gastroesophageal junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Rapid tumoritropic accumulation of systemically injected plateloid particles and their biodistribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Targeted tumor-penetrating siRNA nanocomplexes for credentialing the ovarian cancer oncogene ID4

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Minimal "Self" peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Transferrin receptor is a marker of malignant phenotype in human pancreatic cancer and in neuroendocrine carcinoma of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Transferrin receptor targeting nanomedicine delivering wild-type p53 gene sensitizes pancreatic cancer to gemcitabine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Phase I study of a systemically delivered p53 nanoparticle in advanced solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Specialization of tumour vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Tissue-penetrating delivery of compounds and nanoparticles into tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Fullerenol-cytotoxic conjugates for cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Harnessing structure-activity relationship to engineer a cisplatin nanoparticle for enhanced antitumor efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Antitumor activity and prolonged survival by carbon-nanotube-mediated therapeutic siRNA silencing in a human lung xenograft model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Molecular mechanisms of drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Mechanisms of chemoresistance in cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

A phase III randomized study of oral verapamil as a chemosensitizer to reverse drug resistance in patients with refractory myeloma. A Southwest Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Potent siRNA inhibitors of ribonucleotide reductase subunit RRM2 reduce cell proliferation in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Therapeutic application of small interfering RNA directed against bcr-abl transcripts to a patient with imatinib-resistant chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Immunoconjugated gold nanoshell-mediated photothermal ablation of trastuzumab-resistant breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Multilayer coating of gold nanorods for combined stability and biocompatibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Optimization in interstitial plasmonic photothermal therapy for treatment planning

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Photothermal cancer therapy via femtosecond-laser-excited FePt nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Co-encapsulation of magnetic nanoparticles and doxorubicin into biodegradable microcarriers for deep tissue targeting by vascular MRI navigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Nanoscale radiotherapy with hafnium oxide nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Lipid-derived nanoparticles for immunostimulatory RNA adjuvant delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Humoral immune responses in patients vaccinated with 1-146 HER2 protein complexed with cholesteryl pullulan nanogel

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8⁺ T-cell responses in melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Combined clinical trial results of a HER2/neu (E75) vaccine for the prevention of recurrence in high-risk breast cancer patients: U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Dendritic cell activation and T cell priming with adjuvant- and antigen-loaded oxidation-sensitive polymersomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

In situ regulation of DC subsets and T cells mediates tumor regression in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Lymphotropic nanoparticle-enhanced magnetic resonance imaging (LNMRI) identifies occult lymph node metastases in prostate cancer patients prior to salvage radiation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Lipidoid-coated iron oxide nanoparticles for efficient DNA and siRNA delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Multistage nanoparticle delivery system for deep penetration into tumor tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Molecular mapping of tumor heterogeneity on clinical tissue specimens with multiplexed quantum dots

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

In vivo assembly of nanoparticle components to improve targeted cancer imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Geometrical confinement of gadolinium-based contrast agents in nanoporous particles enhances T1 contrast

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

A brain tumor molecular imaging strategy using a new triple-modality MRI-photoacoustic-Raman nanoparticle

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Chemical exchange saturation transfer (CEST): what is in a name and what isn't?

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

In vivo multicolor molecular MR imaging using diamagnetic chemical exchange saturation transfer liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

MRI-detectable pH nanosensors incorporated into hydrogels for in vivo sensing of transplanted-cell viability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Real-time, aptamer-based tracking of circulating therapeutic agents in living animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Rapid, massively parallel single-cell drug response measurements via live cell interferometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Integrative systems control approach for reactivating Kaposi's sarcoma-associated herpesvirus (KSHV) with combinatory drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Closed-loop control of cellular functions using combinatory drugs guided by a stochastic search algorithm

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

High-throughput methods for combinatorial drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Two-wave nanotherapy to target the stroma and optimize gemcitabine delivery to a human pancreatic cancer model in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Immunotargeted nanoshells for integrated cancer imaging and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Long term in vivo biotransformation of iron oxide nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

Iron-based ferritin nanocore as a contrast agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005872

10.1126/SCITRANSLMED.3005872

21 January 2018

Identifiers

DOI

1 reference

30 August 2017

1 reference